4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001532218-26-000002
CHAIRMAN & CEO gave up 10,313 shares (to pay taxes)
- CHAIRMAN & CEO acquired 21,327 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Patel Sanj K · CHAIRMAN & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-01 | Exercise or conversion : show line 1 in the form | +21,327 | 81,327 | I | ||
| 2026-04-01 | Shares withheld for taxes : show line 2 in the form | −10,313 | $48.13 | $496,365 | 71,014 | I |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-01 | Grant or award : show line 3 in the form Share Option | +120,150 | 120,150 | D |
| 2026-04-01 | Grant or award : show line 4 in the form Restricted Share Unit | +30,050 | 30,050 | D |
| 2026-04-01 | Grant or award : show line 5 in the form Performance Share Unit | +60,100 | 60,100 | D |
| 2026-04-01 | Exercise or conversion : show line 6 in the form Restricted Share Unit | −6,481 | 6,481 | D |
| 2026-04-01 | Exercise or conversion : show line 7 in the form Restricted Share Unit | −6,237 | 12,475 | D |
| 2026-04-01 | Exercise or conversion : show line 8 in the form Restricted Share Unit | −8,609 | 25,826 | D |
Loading xslF345X06/form4-04032026_080457.xml…